Author

Amy H. Porter

QIMR Berghofer Medical Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Alexander P. SobinoffiD· 1 shared Axia SongiD· 1 shared Billy Michael Chelliah JebarajiD· 1 shared Claudia BruedigamiD· 1 shared Florian Heinrich HeideliD· 1 shared G. A. KennedyiD· 1 shared Gerjanne Vroeg in de WeiiD· 1 shared Guidan Cheng· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander P. SobinoffORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNature CancerPeer-reviewedOct 30, 2023

Imetelstat-Mediated Alterations in Fatty Acid Metabolism To Induce Ferroptosis As Therapeutic Strategy for Acute Myeloid Leukemia

Claudia Bruedigam, Amy H. Porter, Axia Song…·Steven Lane

This study identifies ferroptosis as a mechanism by which imetelstat induces therapeutic effects in AML, showing that targeting fatty acid metabolism enhances its efficacy.

94 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky